4be2: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[ | ==PFV intasome with inhibitor XZ-259== | ||
<StructureSection load='4be2' size='340' side='right' caption='[[4be2]], [[Resolution|resolution]] 2.38Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[4be2]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_spumaretrovirus Human spumaretrovirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BE2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BE2 FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=XZ2:2-(3-CHLORO-4-FLUOROBENZYL)-6,7-DIHYDROXY-N,N-DIMETHYL-1-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-SULFONAMIDE'>XZ2</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2x6n|2x6n]], [[2x6s|2x6s]], [[2x74|2x74]], [[2x78|2x78]], [[4bac|4bac]], [[4bdy|4bdy]], [[4bdz|4bdz]], [[4be0|4be0]], [[4be1|4be1]]</td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4be2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4be2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4be2 RCSB], [http://www.ebi.ac.uk/pdbsum/4be2 PDBsum]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Based on a series of lactam and phthalimide derivatives that inhibit HIV-1 integrase, we developed a new derivative, XZ-259, with biochemical and antiviral activities comparable to raltegravir. We determined the crystal structures of XZ-259 and four other derivatives in complex with the prototype foamy virus intasome. The compounds bind at the integrase-Mg2+-DNA interface of the integrase active site. In biochemical and antiviral assays, XZ-259 inhibits raltegravir-resistant HIV-1 integrases harboring the Y143R mutation. Molecular modeling is also presented suggesting that XZ-259 can bind in the HIV-1 intasome with its dimethyl sulfonamide group adopting two opposite orientations. Molecular dynamics analyses of the HIV-1 intasome highlight the importance of the viral DNA in drug potency. | |||
Activities, crystal structures and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase.,Metifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y ACS Chem Biol. 2012 Oct 17. PMID:23075516<ref>PMID:23075516</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
== References == | |||
<references/> | |||
== | __TOC__ | ||
</StructureSection> | |||
[[Category: Human spumaretrovirus]] | [[Category: Human spumaretrovirus]] | ||
[[Category: Cherepanov, P | [[Category: Cherepanov, P]] | ||
[[Category: Hare, S | [[Category: Hare, S]] | ||
[[Category: Dna integration]] | [[Category: Dna integration]] | ||
[[Category: Dna-binding]] | [[Category: Dna-binding]] | ||
Revision as of 15:48, 9 December 2014
PFV intasome with inhibitor XZ-259
| ||||||||||||
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Human spumaretrovirus
- Cherepanov, P
- Hare, S
- Dna integration
- Dna-binding
- Endonuclease
- Hhcc motif
- Inhibitor
- Metal-binding
- Multifunctional enzyme
- Nuclease
- Nucleotidyltransferase
- Nucleus
- Recombination
- Recombination-inhibitor-dna complex
- Transferase
- Transferase-dna complex
- Viral nucleoprotein
- Viral protein
- Virion
- Zinc binding